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Background: Acute coronary syndrome (ACS) and stable coronary artery disease (CAD) constitute a high risk population. N-terminal pro B-type 
natriuretic peptide (NT-proBNP) has been shown to be associated with mortality of CAD. However, not much information about NT-proBNP in the 
risk assessment of elderly CAD patients is available. The present study was to estimate the prognostic value of NT-proBNP in the elderly with ACS or 
stable CAD
Methods: The study was consisted of 999 the elderly (over 60 year) with CAD including stable CAD and ACS, a mean follow-up period was 417 days 
(15 months). All-cause mortality was as the end point
Results: In 707 stable CAD patients, 138 died (19.5%), 292 ACS patients, 77 died (26.4%). NT-proBNP (ln) was significantly related to all-cause 
death in patients with ACS (P<0.001, OR: 1.760, 95% CI: 1.543-2.007), stable CAD (P<0.001, OR: 1.739, 95% CI: 1.577-1.917). The independent 
risk factors of mortality were age, AMI, chronic heart failure (CHF), blood glucose, serum triglyceride and NT-proBNP for ACS, were age, hemoglobin, 
plasma albumin, neutrophil/ lymphocytes ratio, fibrinogen, ejection fraction, left ventricular mass index, left atrial diameter and NT-proBNP for 
stable CAD. The addition of NT-proBNP (ln) to GRACE RS (0.835 vs 0.775, P=0.001) or EHAS (0.784 vs 0.605, P<0.0001) increased significantly the 
c-statistic, even c-statistic of NT-proBNP (ln) was statistically higher than EHAS (0.783 vs 0.605, P<0.0001). The c-statistics of two models in this 
study were obviously higher than that of GRACE RS (0.862 vs 0.775, P=0.0006) or EHAS (0.881 vs 0.605, P<0.0001). NT-proBNP was bound up with 
the GRACE RS (r=0.611, P<0.001) or EHAS (r=0.357, P<0.001). NT-proBNP could be identified by CHF, cardiac systolic dysfunction (LVEF<40%), left 
ventricular hypertrophy, ACS, atrial fibrillation and chronic kidney disease with the c-statistic of 0.758, 0.850, 0.745, 0.577, 0.683, 0.668 and 0.681
Conclusions: NT-proBNP, as a integrated and superimposed predictor, had incremental prognostic value beyond GRACE RS and EHAS in Chinese 
elderly patients with CAD. New models based on NT-proBNP might be helpful in defining risk and guiding therapy to reduce mortality
